Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic ...

Abbott has received FDA Clearance for its FreeStyle Libre Pro system, a key milestone in bringing the company's unique take on the continuous glucose monitor to the United States. In Europe, where the ...

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved the company's FreeStyle ...

Abbott's FreeStyle Libre Pro Flash Glucose Monitoring System is intended for use in the professional setting to help patients with diabetes and clinicians manage the disease. The clinician places the ...

The Freestyle Libre Pro is able to collect up to 14 days worth of continuous glucose results to help doctors better evaluate how people are managing their diabetes. The good news of the approval comes ...

The FDA has approved Abbott’s FreeStyle Libre Pro continuous glucose monitoring system for clinicians to use with diabetic patients. While Abbott markets a consumer version of the FreeStyle Libre in ...

Abbott India’s FreeStyle Libre Pro is finding a firm place in Indian hospitals and clinics as a professional continuous glucose monitoring system that logs 14 days of glucose data without patient ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Diabetes care at Abbott Laboratories ($ABT) has returned to sales growth as ex-U.S. sales ...

SAN FRANCISCO--(BUSINESS WIRE)--Ambrosia announced the availability of LinkBluCon App on Fitbit platform. Now Ambrosia's NightRider BluCon and LinkBluCon app users can use Fitbit Ionic, Versa and ...